Mapping large numbers of results may take a few moments.
Search Results
Showing 201 - 250 of 252 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Ribometrix Inc. | Activity: Research and Development | Company Description Ribometrix is developing a new class of small-molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. | Location Durham | |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham | |
Company RTT Medical | Activity: Research and Development | Company Description RTT Medical provides regenerative tissue technologies for wound management. | Location Winston-Salem | |
Company Sarepta Therapeutics Inc. (Durham) | Activity: Research and Development | Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. | Location Durham | |
Company Satsuma Pharmaceuticals Inc. | Activity: Research and Development | Company Description Satsuma Pharmaceuticals is developing best-in-class intranasal drug products to address the significant unmet medical needs of acute migraine sufferers. | Location Durham | |
Company Shattuck Labs Inc. | Activity: Research and Development | Company Description Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in cancer, inflammation and orphan disease. | Location Durham | |
Company SIF Biopharma LLC | Activity: Research and Development | Company Description SIF Biopharma develops new therapies in the areas of regenerative medicine and cancer. | Location Chapel Hill | |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham | |
Company Solve Therapeutics Inc. | Activity: Research and Development | Company Description Solve Therapeutics develops antibody-drug conjugates (ADC) and antibody-radionuclide conjugates (ARC) for oncology patients. | Location Durham | |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte | |
Company SpringWorks Therapeutics LLC | Activity: Research and Development | Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. | Location Durham | |
Company Sprout Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Sprout Pharmaceuticals has developed and markets a compound to treat hypoactive sexual desire disorder in women who have not gone through menopause. | Location Raleigh | |
Company SPV Therapeutics Inc. | Activity: Research and Development | Company Description SPV Therapeutics is developing small molecule therapeutics to treat cancer. | Location Research Triangle Park | |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary | |
Company Symberix Inc. | Activity: Research and Development | Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases such as Inflammatory Bowel Disorder (IBD) as well as mitigate the lower GI side effects associated with various pain, cancer and immunosuppressive therapies. | Location Durham | |
Company Synoxa Sciences Inc. | Activity: Research and Development | Company Description Synoxa Sciences develops small molecule therapeutics to treat multi-drug resistant (MDR) bacterial pathogens, including those in the biofilm state. | Location Raleigh | |
Company Synthon Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Synthon Pharmaceuticals develops and manufactures generics, as well as specialty pharmaceuticals and biosimilars in key therapeutic areas of oncology and multiple sclerosis. The Durham location is a regulatory office. | Location Research Triangle Park | |
Company T3D Therapeutics Inc. | Activity: Research and Development | Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. | Location Research Triangle Park | |
Company Takeda Vaccines Inc. | Activity: Sales and Operations | Company Description Takeda's Vaccine Business Unit develops vaccines, including norovirus, dengue and seasonal influenza candidate vaccines. | Location Morrisville | |
Company TARGAN Inc. | Activity: Research and Development | Company Description TARGAN is developing automated bio-system solutions for detecting, targeting, and delivering vaccines for the animal health industry. TARGAN's technologies aim to reduce the need for antibiotics by improving vaccination delivery. | Location Raleigh | |
Company Tavros Therapeutics Inc. | Activity: Research and Development | Company Description Tavros is developing first-in-class therapeutics for cancer by using a novel precision oncology platform. | Location Research Triangle Park | |
Company TCRCure Biopharma Corp. | Activity: Research and Development | Company Description TCRCure Biopharma discovers and develops novel therapeutic targets in the field of cancer immunotherapy. | Location Durham | |
Company Tellus Therapeutics Inc. | Activity: Research and Development | Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. | Location Research Triangle Park | |
Company Ten63 Therapeutics Inc. | Activity: Research and Development | Company Description Ten63 Therapeutics uses computational chemistry and AI to screen trillions of molecules to discover new therapeutics for a wide variety of diseases. | Location Durham | |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville | |
Company TG Therapeutics Inc. | Activity: Research and Development | Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. | Location Morrisville | |
Company TheraSplice | Activity: Research and Development | Company Description TheraSplice is developing a precision oncology platform and products. The company has several targets under development in prostate, lung, breast, and liver cancer with the goal of initiating biomarker stratified clinical trials. | Location Chapel Hill | |
Company TheraVida Inc. | Activity: Research and Development | Company Description TheraVida is developing a treatment for primary focal hyperhidrosis. | Location Chapel Hill | |
Company Torque Bio Inc. | Activity: Research and Development | Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. | Location Durham | |
Company TransChromix LLC | Activity: Research and Development | Company Description TransChromix is developing novel therapeutic inventions for chronic inflammation-associated diseases, such as Type 1 diabetes and Alzheimer's disease. | Location Chapel Hill | |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill | |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham | |
Company UCB Biosciences Inc. | Activity: Research and Development | Company Description UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis. | Location Morrisville | |
Company United Therapeutics Corp. (RTP HQ) | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park | |
Company ValanBio Therapeutics Inc. | Activity: Research and Development | Company Description Valanbio Therapeutics is an early-stage anti-infectives company. Valanbio is developing novel antibiotics for Gram-negative organisms. | Location Durham | |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham | |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham | |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville | |
Company Veloxis Pharmaceuticals Inc | Activity: Sales and Operations | Company Description Veloxis Pharmaceuticals is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. | Location Cary | |
Company Verona Pharma Inc. | Activity: Research and Development | Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). | Location Raleigh | |
Company ViiV Healthcare | Activity: Research and Development | Company Description ViiV Healthcare, a joint venture established by GSK and Pfizer, researches and develops new HIV medicines and advances care for people living with HIV. | Location Durham | |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham | |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham | |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point | |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham | |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary | |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary | |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill | |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill | |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh |